Tianjin Lisheng Pharmaceutical Co Ltd (002393) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥81.14 Million ≈ $11.87 Million USD) by net assets (CN¥5.00 Billion ≈ $732.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tianjin Lisheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Tianjin Lisheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002393 current and long-term liabilities for a breakdown of total debt and financial obligations.

Tianjin Lisheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Lisheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Total Energy Services Inc. TO:TOT	0.097x
WhiteFiber, Inc. Ordinary Shares NASDAQ:WYFI	-0.035x
Thanh Thanh Cong Tay Ninh JSC VN:SBT	-0.053x
Zhewen Pictures Group Co Ltd SHG:601599	0.048x
Holike SHG:603898	-0.001x
Thesis Gold Inc V:TAU	-0.019x
Changchun Zhiyuan New Energy Equipment Co. Ltd SHE:300985	0.112x
Hoang Huy Investment Financial VN:TCH	0.067x

Annual Cash Flow Conversion Efficiency for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Tianjin Lisheng Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.80 Billion ≈ $702.39 Million	CN¥88.26 Million ≈ $12.92 Million	0.018x	-56.96%
2023-12-31	CN¥4.90 Billion ≈ $717.53 Million	CN¥209.51 Million ≈ $30.66 Million	0.043x	-43.92%
2022-12-31	CN¥4.35 Billion ≈ $636.45 Million	CN¥331.38 Million ≈ $48.49 Million	0.076x	+71.15%
2021-12-31	CN¥4.41 Billion ≈ $645.40 Million	CN¥196.34 Million ≈ $28.73 Million	0.045x	+150.77%
2020-12-31	CN¥4.30 Billion ≈ $629.53 Million	CN¥76.37 Million ≈ $11.18 Million	0.018x	-70.78%
2019-12-31	CN¥4.42 Billion ≈ $646.32 Million	CN¥268.33 Million ≈ $39.26 Million	0.061x	+19.96%
2018-12-31	CN¥3.21 Billion ≈ $470.07 Million	CN¥162.69 Million ≈ $23.81 Million	0.051x	-12.99%
2017-12-31	CN¥3.08 Billion ≈ $450.66 Million	CN¥179.25 Million ≈ $26.23 Million	0.058x	+1.09%
2016-12-31	CN¥3.02 Billion ≈ $441.21 Million	CN¥173.60 Million ≈ $25.40 Million	0.058x	-13.70%
2015-12-31	CN¥2.97 Billion ≈ $434.60 Million	CN¥198.13 Million ≈ $28.99 Million	0.067x	+168.73%
2014-12-31	CN¥2.91 Billion ≈ $425.81 Million	CN¥72.24 Million ≈ $10.57 Million	0.025x	-74.94%
2013-12-31	CN¥2.92 Billion ≈ $427.86 Million	CN¥289.62 Million ≈ $42.38 Million	0.099x	+10.09%
2012-12-31	CN¥2.79 Billion ≈ $407.77 Million	CN¥250.72 Million ≈ $36.69 Million	0.090x	+87.07%
2011-12-31	CN¥2.80 Billion ≈ $409.46 Million	CN¥134.58 Million ≈ $19.69 Million	0.048x	-31.68%
2010-12-31	CN¥2.65 Billion ≈ $387.79 Million	CN¥186.55 Million ≈ $27.30 Million	0.070x	-83.10%
2009-12-31	CN¥470.87 Million ≈ $68.90 Million	CN¥196.14 Million ≈ $28.70 Million	0.417x	+56.23%
2008-12-31	CN¥474.77 Million ≈ $69.47 Million	CN¥126.59 Million ≈ $18.52 Million	0.267x	-34.13%
2007-12-31	CN¥432.23 Million ≈ $63.25 Million	CN¥174.94 Million ≈ $25.60 Million	0.405x	--

About Tianjin Lisheng Pharmaceutical Co Ltd

SHE:002393 China Drug Manufacturers - Specialty & Generic

Market Cap

$629.47 Million

CN¥4.30 Billion CNY

Market Cap Rank

#11361 Global

#3424 in China

Share Price

CN¥16.70

Change (1 day)

-0.65%

52-Week Range

CN¥16.47 - CN¥27.50

All Time High

CN¥46.19